Css LLC Axsome Therapeutics, Inc. Call Options Transaction History

Css LLC

12 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	BUY	$39.94 - $79.72 $79,880 - $159,440	2,000 Added 7.72%	27,900 $2.15 Million
Q3 2022 Nov 14, 2022	SELL	$36.06 - $69.85 $569,748 - $1.1 Million	-15,800 Reduced 37.89%	25,900 $1.16 Million
Q2 2022 Aug 15, 2022	BUY	$21.74 - $46.75 $386,972 - $832,150	17,800 Added 74.48%	41,700 $1.6 Million
Q1 2022 May 16, 2022	SELL	$23.7 - $41.39 $54,510 - $95,197	-2,300 Reduced 8.78%	23,900 $989,000
Q4 2021 Feb 14, 2022	BUY	$30.7 - $43.36 $52,190 - $73,712	1,700 Added 6.94%	26,200 $990,000
Q3 2021 Nov 15, 2021	BUY	$19.91 - $68.26 $400,191 - $1.37 Million	20,100 Added 456.82%	24,500 $807,000
Q1 2021 May 17, 2021	SELL	$55.91 - $81.44 $408,143 - $594,512	-7,300 Reduced 62.39%	4,400 $249,000
Q4 2020 Feb 16, 2021	BUY	$66.31 - $86.52 $13,262 - $17,304	200 Added 1.74%	11,700 $953,000
Q3 2020 Nov 16, 2020	BUY	$68.34 - $85.84 $34,170 - $42,920	500 Added 4.55%	11,500 $820,000
Q2 2020 Aug 14, 2020	SELL	$49.87 - $98.69 $164,571 - $325,677	-3,300 Reduced 23.08%	11,000 $905,000
Q1 2020 May 15, 2020	SELL	$41.2 - $101.31 $1.72 Million - $4.22 Million	-41,700 Reduced 74.46%	14,300 $842,000
Q4 2019 Feb 14, 2020	BUY	$16.71 - $106.24 $935,760 - $5.95 Million	56,000 New	56,000 $5.79 Million

326

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.99B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.